Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study
- Lancet, Available online 28 March 2019, Volume 393, Issue 10182, Pages 1699-1707 | https://doi.org/10.1016/S0140-6736(18)32196-2